| dc.contributor.author | Scotland, Graham Stewart | |
| dc.date.accessioned | 2015-12-02T12:31:01Z | |
| dc.date.available | 2015-12-02T12:31:01Z | |
| dc.date.issued | 2015-09 | |
| dc.identifier.citation | Scotland , G S 2015 ' Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? HERU Policy Brief ' University of Aberdeen , Aberdeen , pp. 1-2 . | en |
| dc.identifier.other | PURE: 59572637 | |
| dc.identifier.other | PURE UUID: c3398e12-3f01-45e2-b2d5-9883b3c5af19 | |
| dc.identifier.uri | http://hdl.handle.net/2164/5273 | |
| dc.identifier.uri | https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_Sept_2015.pdf | en |
| dc.description | The work carried out for this project was commissioned by NICE and funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of NICE, the NIHR HTA Programme, NIHR, NHS or Department of Health. Investigators and researchers on this project were Pawana Sharma, Graham Scotland, Moira Cruickshank, Emma Tassie, Cynthia Fraser, Christopher Burton, Bernard Croal, Craig R Ramsay, and Miriam Brazzelli. | en |
| dc.format.extent | 2 | en |
| dc.language.iso | eng | |
| dc.publisher | University of Aberdeen | |
| dc.relation.ispartof | | en |
| dc.subject | Warfarin | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? : HERU Policy Brief | en |
| dc.type | Working or discussion paper | en |
| dc.contributor.institution | University of Aberdeen, Health Economics Research Unit | en |
| dc.contributor.institution | University of Aberdeen, Institute of Applied Health Sciences | en |
| dc.description.version | Publisher PDF | en |
